Bio-Techne (TECH) Invested Capital (2013 - 2026)

Bio-Techne has reported Invested Capital for 14 years, with the latest figure at $2.3 billion in Q2 2026.

• On a quarterly basis, Invested Capital rose 1.92% year-over-year to $2.3 billion in Q2 2026; TTM through Jun 2026 was $2.3 billion, a 1.92% increase from a year earlier, with the FY2026 full-year figure at $2.3 billion, up 1.92% from the prior year.
• Invested Capital was $2.3 billion for Q2 2026 at Bio-Techne, up from $2.3 billion in the prior quarter.
• The five-year high for Invested Capital was $2.4 billion in Q3 2023, with the low at $2.0 billion in Q2 2022.
• Average Invested Capital over 5 years is $2.3 billion, with a median of $2.3 billion recorded in 2026.
• The sharpest annual moves came in 2023 and 2025: Invested Capital increased 20.58% in 2023, then slipped 7.09% in 2025.
• Over 5 years, Invested Capital stood at $2.0 billion in 2022, then rose by 18.92% to $2.4 billion in 2023, then dropped by 1.33% to $2.4 billion in 2024, then decreased by 4.52% to $2.3 billion in 2025, then climbed by 1.64% to $2.3 billion in 2026.
• The last three Invested Capital figures came in at $2.3 billion (Q2 2026), $2.3 billion (Q1 2026), and $2.3 billion (Q4 2025), per Business Quant data.